Drugs / Pneumovax Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01924169 | Nov 2014 → Feb 2017 | hematologic disorder | M.D. Anderson Cancer Center | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pneumovax Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01924169 ↗ |
| Modality | Vaccine | “you will receive a vaccine for pneumonia (Pneumovax) between months 6 and 21.” NCT01924169 ↗ |
| Route | Subcutaneous | “You will receive these vaccines as an injection under the skin.” NCT01924169 ↗ |